Literature DB >> 6602068

Human interleukin 1: purification and properties.

L B Lachman.   

Abstract

Human interleukin 1 (IL 1) has been purified to homogeneity by a procedure of molecular weight fractionation, isoelectric focusing, and preparative polyacrylamide gel electrophoresis. The homogeneity of the purified material has been demonstrated by silver staining of analytical polyacrylamide gels. The homogeneous IL 1 retains only a trace of its original biological activity because of the denturing effects of the sodium dodecyl sulfate used in the final step of purification. Very highly purified IL 1, retaining strong biological activity, has been eluted from nondenaturing polyacrylamide gels. This IL 1 has been demonstrated to stimulate human and mouse T and B lymphocytes, fibroblasts, and synovial cells. In addition, in vivo treatment of animals with IL 1 resulted in the immunologically relevant symptoms of fever, increased plasma levels of acute phase proteins, and increased numbers of circulating neutrophils.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602068

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  24 in total

1.  Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171.

Authors:  A E Postlethwaite; G N Smith; L B Lachman; R O Endres; H M Poppleton; K A Hasty; J M Seyer; A H Kang
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 2.  The molecular forms of interleukin-1.

Authors:  T P Hopp; S K Dower; C J March
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation.

Authors:  J W Mannhalter; H O Neychev; G J Zlabinger; R Ahmad; M M Eibl
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

4.  Candida albicans polysaccharide extract (MPPS) and PPD stimulate the production of interleukin-1 and lymphocyte proliferation.

Authors:  G Lombardi; E Piccolella; D Vismara; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

5.  Dissociation between interleukin-1 and interleukin-2 production in proliferative response to microbial antigens: restorative effect of exogenous interleukin-2.

Authors:  D Vismara; G Lombardi; E Piccolella; V Colizzi
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.

Authors:  J F Sheridan; L Aurelian; A D Donnenberg; T C Quinn
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

7.  Evidence for an intracellular precursor for human B-cell growth factor.

Authors:  C G Sahasrabuddhe; J Morgan; S Sharma; S Mehta; B Martin; D Wright; A Maizel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 8.  An update on human interleukin-1: from molecular biology to clinical relevance.

Authors:  C A Dinarello
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

9.  Autologous mixed lymphocyte reaction in man. XIV. Deficiency of the autologous mixed lymphocyte reaction in acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC). In vitro effect of purified interleukin-1 and interleukin-2.

Authors:  S Gupta; S Gillis; M Thornton; M Goldberg
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

10.  Multiple biological activities of human recombinant interleukin 1.

Authors:  C A Dinarello; J G Cannon; J W Mier; H A Bernheim; G LoPreste; D L Lynn; R N Love; A C Webb; P E Auron; R C Reuben
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.